| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Robin James Scott Cridland, Derek McAllan |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 3.27p |
| Change Today | 0.22p |
| % Change | 7.10 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 700,058 |
| Shares Issued | 533.35m |
| Market Cap | £17.42m |
| Beta | 0.78 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:38 | 46,135 @ 3.26p |
| 10:24 | 50,000 @ 3.40p |
| 10:16 | 2,500 @ 3.31p |
| 09:53 | 36,056 @ 3.32p |
| 09:36 | 443 @ 3.39p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research